These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32175324)

  • 21. Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare.
    Janssen CA; Oude Voshaar MAH; Ten Klooster PM; Vonkeman HE; van de Laar MAFJ
    Clin Rheumatol; 2019 Aug; 38(8):2233-2239. PubMed ID: 31030363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of urate-lowering drugs with the risk of future urolithiasis in patients with gout: A population-based nested case-control study.
    Wu SW; Liu CY; Yeh CJ; Wang YH; Cheng-Chung Wei J
    Int J Clin Pract; 2021 Aug; 75(8):e14283. PubMed ID: 33914376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-gout Medications and Risk of Cardiovascular Disease: A Nested Case-Control Study.
    Chuang TJ; Wang YH; Wei JC; Yeh CJ
    Front Med (Lausanne); 2021; 8():739680. PubMed ID: 34733863
    [No Abstract]   [Full Text] [Related]  

  • 24. Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study.
    Pisaniello HL; Lester S; Gonzalez-Chica D; Stocks N; Longo M; Sharplin GR; Dal Grande E; Gill TK; Whittle SL; Hill CL
    Arthritis Res Ther; 2018 Jul; 20(1):143. PubMed ID: 29996922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between urate-lowering therapy initiation and all-cause mortality in patients with type 2 diabetes and asymptomatic hyperuricemia.
    Chen R; Nie S; Zhou S; Su L; Li Y; Zhang X; Luo F; Xu R; Gao Q; Lin Y; Guo Z; Cao L; Xu X;
    Diabetes Metab Syndr; 2024 May; 18(6):103043. PubMed ID: 38908114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of the initiation time of urate-lowering therapy in gout patients: A retrospective research.
    Feng X; Li Y; Gao W
    Joint Bone Spine; 2015 Dec; 82(6):428-31. PubMed ID: 26456042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia.
    Levy GD; Rashid N; Niu F; Cheetham TC
    J Rheumatol; 2014 May; 41(5):955-62. PubMed ID: 24692523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperuricemia in Patients With Coronary Artery Disease and Its Association With Disease Severity.
    Padda J; Khalid K; Almanie AH; Al Hennawi H; Mehta KA; Wijeratne Fernando R; Padda S; Cooper AC; Jean-Charles G
    Cureus; 2021 Aug; 13(8):e17161. PubMed ID: 34532188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
    Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
    Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy.
    Latourte A; Bardin T; Clerson P; Ea HK; Flipo RM; Richette P
    Arthritis Care Res (Hoboken); 2018 Jun; 70(6):918-924. PubMed ID: 28834411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of a urate lowering regimen in primary gout.
    Bailén R; González Senac NM; López MM; Llena ML; Migoya M; Rodríguez MT; de Miguel E; Torres RJ; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):174-80. PubMed ID: 24940666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment approaches and adherence to urate-lowering therapy for patients with gout.
    Aung T; Myung G; FitzGerald JD
    Patient Prefer Adherence; 2017; 11():795-800. PubMed ID: 28458524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gout management: an update].
    Ankli B; Krähenbühl S
    Ther Umsch; 2016; 73(3):115-24. PubMed ID: 27008442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.
    Graham GG; Stocker SL; Kannangara DRW; Day RO
    Curr Rheumatol Rep; 2018 Jun; 20(8):47. PubMed ID: 29931553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients.
    Chung TT; Yu KH; Kuo CF; Luo SF; Chiou MJ; Lan WC; Chen JS; Tseng WY; Hsieh AH; Wang LC
    Arthritis Res Ther; 2019 Sep; 21(1):210. PubMed ID: 31533805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beliefs of rheumatologists and general practitioners on urate lowering therapy: a cross-sectional study.
    Veenstra F; Vriezekolk JE; van den Bemt BJF; Schers HJ; Sloot B; van den Ende CHM; van Herwaarden N; Flendrie M
    Rheumatol Adv Pract; 2023; 7(2):rkad033. PubMed ID: 37113501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort.
    Liang N; Sun M; Sun R; Xu T; Cui L; Wang C; Ma L; Cheng X; Xue X; Sun W; Yuan X; Zhang H; Li H; He Y; Ji A; Wu X; Li C
    Arthritis Res Ther; 2019 Sep; 21(1):200. PubMed ID: 31477161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing attacks of acute gout when introducing urate-lowering therapy: a systematic literature review.
    Seth R; Kydd AS; Falzon L; Bombardier C; van der Heijde DM; Edwards CJ
    J Rheumatol Suppl; 2014 Sep; 92():42-7. PubMed ID: 25180127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the initiation of urate-lowering treatment during an acute gout attack prolong the current episode and precipitate recurrent attacks: a systematic literature review.
    Eminaga F; La-Crette J; Jones A; Abhishek A
    Rheumatol Int; 2016 Dec; 36(12):1747-1752. PubMed ID: 27761603
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.